INTRODUCING OVAGEN...
...The world's first economically sustainable production of germ-free eggs and antibodies.
• Ovagen is a biotechnology company that has developed a patented process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry housing & husbandry, in specific poultry research technologies to GMP standards and in avian transgenics.
• Our innovative disruptive technology will be a game changer for the vaccine industry as currently eggs produced from clean or SPF laying flocks can be infected with bacteria and viruses therefore Germ-free eggs provide many advantages over current sources of eggs including: A safe, biosecure, large scale, flexible and cost effective biomanufacturing platform for the production of vaccines and therapeutic proteins
• Zero contamination from germ free eggs and increased viral yield
- Leads to cost saving and greater continuity of supply and superior quality vaccines
- Removes the risk of egg-derived contamination of vaccines, eliminating batch losses and ensuring companies can meet demand. This is essential as the world comes to grips with COVID-19 and future pandemics creating enormous demand for vaccines
• GF eggs are produced to GMP fully compliant with USDA Memo 800.65 and European Pharmacopoeia requirements.
Applications of Germ Free (GF) Eggs/Cells/Tissues
1. Conventional (prophylactic) vaccines
- Whole egg
- Primary cell cultures
- MVA-based (e.g. bioterrorism vaccines)
- Other pox virus based vaccines
2. Therapeutic vaccines
- Cancer vaccines (e.g. MVA-based Cervical (HPV) vaccine, Lung (NSC) vaccines)
- Infections agents (e.g. HIV)
3. Pharmaceutical (e.g. hyaluronic acid, phospholipids) |